Interaction of cholinergic function with mg2 plus-na plus-k plus-dependent ATP-ase system of cells in the human fundic gastric mucosa.
D000109:Acetylcholine / Q000494:pharmacology; D000251:Adenosine Triphosphatases / Q000378:metabolism*; D001285:Atropine / Q000494:pharmacology; D001693:Biological Transport, Active; D001965:Bromides / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002462:Cell Membrane / Q000187:drug effects* / Q000201:enzymology; D005753:Gastric Mucosa / Q000187:drug effects* / Q000201:enzymology; D006801:Humans; D008274:Magnesium / Q000378:metabolism; D009388:Neostigmine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology*; D010277:Parasympathomimetics / Q000494:pharmacology*; D010437:Peptic Ulcer / Q000201:enzymology; D011188:Potassium / Q000378:metabolism; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D012964:Sodium / Q000378:metabolism; D013268:Stimulation, Chemical
D001965:Bromides; D010276:Parasympatholytics; D010277:Parasympathomimetics; D000644:Quaternary Ammonium Compounds; D011950:Receptors, Cholinergic; D009388:Neostigmine; D001285:Atropine; D002217:Carbachol; D012964:Sodium; D000251:Adenosine Triphosphatases; D008274:Magnesium; D000109:Acetylcholine; D011188:Potassium